imidazole has been researched along with HIV Infections in 2 studies
imidazole: RN given refers to parent cpd
1H-imidazole : An imidazole tautomer which has the migrating hydrogen at position 1.
HIV Infections: Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ylisastigui, L | 1 |
| Coull, JJ | 1 |
| Rucker, VC | 1 |
| Melander, C | 1 |
| Bosch, RJ | 1 |
| Brodie, SJ | 1 |
| Corey, L | 1 |
| Sodora, DL | 1 |
| Dervan, PB | 1 |
| Margolis, DM | 1 |
| Chiritescu, MM | 1 |
| Chiritescu, ME | 1 |
| Scher, RK | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| IGHID 11424 - A Pilot Trial of the Effect of Vorinostat and AGS-004 on Persistent HIV-1 Infection (The VOR VAX Study)[NCT02707900] | Phase 1 | 6 participants (Actual) | Interventional | 2016-03-31 | Terminated (stopped due to Manufacturing of the AGS-004 HIV vaccine by Argos could no longer be provided.) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for imidazole and HIV Infections
| Article | Year |
|---|---|
Newer systemic antifungal drugs for the treatment of onychomycosis.
Topics: Aged; Antifungal Agents; Child; Enzyme Inhibitors; Female; Griseofulvin; HIV Infections; Humans; Imi | 1996 |
1 other study available for imidazole and HIV Infections
| Article | Year |
|---|---|
Polyamides reveal a role for repression in latency within resting T cells of HIV-infected donors.
Topics: Anti-HIV Agents; CD4-Positive T-Lymphocytes; Cells, Cultured; Enzyme Inhibitors; Histone Deacetylase | 2004 |